Budget Impact Analysis of Biosimilar Products in Spain in the Period 2009–2019

por García-Goñi, Manuel, Río-Álvarez, Isabel, Carcedo, David, Villacampa, Alba
Publicado 2021

Estimation of the Clinical and Economic Impact of an Improvement in Adherence Based on the Use of Once-Daily Single-Inhaler Triple Therapy in Patients with COPD

por Miravitlles, Marc, Marín, Alicia, Huerta, Alicia, Carcedo, David, Villacampa, Alba, Puig-Junoy, Jaume
Publicado 2020

Treatment patterns, resource use and costs of idiopathic pulmonary fibrosis in Spain – results of a Delphi Panel

por Morell, Ferran, Esser, Dirk, Lim, Jonathan, Stowasser, Susanne, Villacampa, Alba, Nieves, Diana, Brosa, Max
Publicado 2016

Cost-effectiveness of combination therapy umeclidinium/vilanterol versus tiotropium in symptomatic COPD Spanish patients

por Miravitlles, Marc, Gáldiz, Juan B, Huerta, Alicia, Villacampa, Alba, Carcedo, David, Garcia-Rio, Francisco
Publicado 2016